- Home
- IRMD vs LEU Comparison
IRMD vs LEU Comparison
Compare IRMD & LEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRMD
- LEU
- Stock Information
- Founded
- IRMD 1992
- LEU 1998
- Country
- IRMD United States
- LEU United States
- Employees
- IRMD N/A
- LEU N/A
- Industry
- IRMD Medical/Dental Instruments
- LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- IRMD Health Care
- LEU Industrials
- Exchange
- IRMD Nasdaq
- LEU Nasdaq
- Market Cap
- IRMD 766.5M
- LEU 1.3B
- IPO Year
- IRMD 2014
- LEU 1998
- Fundamental
- Price
- IRMD $62.95
- LEU $83.63
- Analyst Decision
- IRMD Strong Buy
- LEU Buy
- Analyst Count
- IRMD 1
- LEU 2
- Target Price
- IRMD $60.00
- LEU $92.00
- AVG Volume (30 Days)
- IRMD 36.9K
- LEU 726.1K
- Earning Date
- IRMD 02-13-2025
- LEU 02-06-2025
- Dividend Yield
- IRMD 0.98%
- LEU N/A
- EPS Growth
- IRMD 13.16
- LEU 50.42
- EPS
- IRMD 1.46
- LEU 4.70
- Revenue
- IRMD $71,305,130.00
- LEU $394,000,000.00
- Revenue This Year
- IRMD $13.60
- LEU $25.25
- Revenue Next Year
- IRMD $10.46
- LEU $5.68
- P/E Ratio
- IRMD $41.82
- LEU $17.17
- Revenue Growth
- IRMD 13.23
- LEU 14.94
- 52 Week Low
- IRMD $40.18
- LEU $33.51
- 52 Week High
- IRMD $61.25
- LEU $118.36
- Technical
- Relative Strength Index (RSI)
- IRMD 67.60
- LEU 50.41
- Support Level
- IRMD $57.96
- LEU $77.01
- Resistance Level
- IRMD $61.09
- LEU $85.60
- Average True Range (ATR)
- IRMD 1.63
- LEU 5.90
- MACD
- IRMD 0.04
- LEU -0.36
- Stochastic Oscillator
- IRMD 88.56
- LEU 28.71
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
About LEU Centrus Energy Corp.
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.